ArticleVaccines2022

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV.

Shu-Hsing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.